Jan 19, 2019
- Data from two recent studies presented at NANS 2019 demonstrate key benefits of BurstDR™ stimulation
- Microdosing BurstDR stimulation at lowest effective energy allows patients to manage their pain without the burden of recharging their devices
- Additional data further showed switching from other types of SCS therapies to Abbott’s BurstDR stimulation significantly reduced pain and the need for opioid medication